semaglutide and autoimmune GLP-1 Inflammation: How These Drugs Ease Arthritis Possible mechanisms of semaglutide on

The manufacturers website lists various savings options

do not use if you have a history of severe gastrointestinal disease Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness) While this is rare with GLP-1s, if it occurs, please seek in-person care immediately

Liraglutide (Saxenda) is an alternative GLP-1 agonist made by Novo Nordisk, available as a daily injection, licensed for weight loss by the Food and Drug Administration in the USA

And because rapid weight loss can sometimes mask underlying nutritional or metabolic issues, having access to more detailed health data can be especially valuable

Similarly, health care providers should ask themselves some questions before prescribing these drugs to their older patients: Does my patient have signs of impaired mobility, and could they be worsened by loss of muscle mass

This association has been observed in various models, including non-amyloid models of Alzheimers disease (Viana da Silva et al